血尿治疗市场规模预计将从 2023 年的 9.8 亿美元增至 2031 年的 19.8 亿美元。预计 2023-2031 年期间市场复合年增长率将达到 2.5%。对先进疗法的偏好上升可能仍将是市场的主要趋势。
血尿治疗市场分析
推动市场增长的关键因素是血尿相关适应症的高发性、对治疗方案的认识不断提高以及医疗支出的改善,这些都是推动血尿治疗市场发展的因素。此外,医疗设备和诊断程序的技术发展带来了各种治疗血尿相关适应症的选择,例如肾结石、膀胱结石和尿路感染,这很可能为未来几年的血尿治疗市场提供机会。
血尿治疗市场概况
慢性肾病 (CKD) 是一种常见且危及生命的疾病,影响着全球大量人口。CKD 有多种类型,例如肾结石、肾小球肾炎、多囊肾病和尿路感染。CKD 是血尿流行的根本原因之一。例如,根据 2019 年 5 月美国国家生物技术信息中心发表的一项研究,尿路感染 (UTI) 在美国通常被视为门诊感染,主要发生在 14 至 24 岁年龄段的女性中。此外,65 岁以上女性的 UTI 患病率约为 20%,而总人口约为 11%。目前,全球血尿治疗市场正因相关适应症的日益流行而大幅增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
血尿治疗市场:
复合年增长率(2023 - 2031)2.5%- 2023 年市场规模
9.8 亿美元 - 2031年市场规模
19.8亿美元
市场动态
- 相关适应症的明确治疗算法正在推动市场增长
- 相关适应症的流行率上升为全球血尿治疗市场带来机遇
- 患者对治疗的认识不断提高,推动了血尿治疗市场的发展。
关键人物;主力;重要一员
- 阿斯利康
- 默克公司
- 百时美施贵宝公司
- 默克公司
- F.霍夫曼-拉罗氏有限公司HOFFMANN-LA ROCHE LTD.
- 葛兰素史克公司 plc.
- 杨森制药 Pharmaceuticals
- 诺华公司
- 辉瑞公司
- 勃林格殷格翰国际有限公司 Ingelheim International GmbH
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 药物
- 疗法
- 泌尿道感染
- 肾结石
- 尿道炎
- 血癌
- 膀胱结石
- 前列腺癌
- 膀胱炎
- 创伤
- 剧烈运动
- 多囊肾
- 子宫内膜异位症
- 经期
- 肉眼血尿
- 镜下血尿
- 特发性血尿
- 慢跑者血尿
- 医院
- 诊所
- ASC 的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
血尿治疗市场驱动因素和机遇
提高对治疗选择的认识并改善医疗支出
由于慢性病患病率不断上升,医疗支出大幅增加。各经济体的政府都在大力投资改善医疗基础设施。例如,根据美国医疗保险和医疗补助服务中心(CMS)2020年12月发布的数据,国民医疗支出(NHE)增长约4.6%,达到每人11,582美元,约占国内生产总值(GDP)的17.7%。此外,CMS预测,到2020年4月,美国的医疗支出预计将达到约6.19万亿美元。
此外,发达经济体的患者开始意识到血尿治疗的可能治疗方法和报销的可能性。血尿是血癌、膀胱癌和肾癌等慢性疾病的初期症状之一。这些疾病受到各种健康保险政策的覆盖,有助于减轻患者的治疗费用并减轻医疗保健的经济负担。因此,改善医疗保健支出和患者对治疗的认识正在推动血尿治疗市场的发展。
增加相关治疗的机会
由于肾结石和尿路感染的增加,人口老龄化更容易患上血尿疾病,这是推动市场扩张的主要驱动力之一。先进治疗技术的使用有望加强对患者的护理。例如,近年来,机器人技术在治疗泌尿结石的手术中的应用越来越受欢迎。目前,Intuitive Surgical Inc. 的 Vinci 手术系统被广泛用于治疗泌尿结石的手术。同样,在北美、欧洲和亚洲各国,肾结石的泌尿外科腔内干预措施的使用率也显著增加。预计在预测期内,相关适应症的进展也将支持全球血尿治疗市场。
血尿治疗市场报告细分分析
有助于得出血尿治疗市场分析的关键部分是产品类型、适应症类型和最终用户。
- 根据治疗方法,血尿治疗市场分为药物、疗法和其他。药物部分在 2023 年占据了最大的市场份额。
- 根据适应症,血尿治疗市场细分为泌尿道感染、肾结石、尿道炎、血癌、膀胱结石、前列腺癌、膀胱炎、创伤、剧烈运动、多囊肾病、子宫内膜异位症、月经。泌尿道感染细分市场在 2023 年占据最大市场份额。
- 根据最终用户,血尿治疗市场分为医院、诊所和 ASC 等。医院部分在 2023 年占据了最大的市场份额。
血尿治疗市场份额按地区分析
血尿治疗市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。
在北美,美国是最大的血尿治疗市场。该市场的增长主要得益于慢性肾病 (CKD) 患病率的不断上升以及主要参与者推出的产品数量不断增加。例如,2016 年,美国疾病控制与预防中心 (CDC) 表示,美国估计有 70 万人接受终末期肾病 (ESRD) 治疗。1990 年至 2016 年间,ESRD 患病率增加了一倍多。此外,成人血尿发病率的增加、认识的提高以及广泛的研发活动也有望推动血尿治疗的普及,最终将为市场增长提供有利可图的机会。
血尿治疗市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 9.8亿美元 |
2031 年市场规模 | 19.8亿美元 |
全球复合年增长率(2023 - 2031) | 2.5% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按治疗
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
血尿治疗市场新闻和最新发展
通过收集一级和二级研究后的定性和定量数据来评估血尿治疗市场,其中包括重要的公司出版物、协会数据和数据库。血尿治疗市场的一些发展如下所列:
- 阿斯利康的 Farxiga(达格列净)已在美国获批,用于降低心力衰竭成人患者心血管 (CV) 死亡、心力衰竭 (CHF) 住院和紧急心力衰竭 (HF) 就诊风险。美国食品药品管理局 (FDA) 的批准是基于 DELIVER III 期试验的积极结果。1 Farxiga 此前已在美国获批用于治疗射血分数降低 (HFrEF) 的心力衰竭成人患者。(来源:阿斯利康公司网站,2023 年 5 月)
血尿治疗市场报告范围和交付成果
“血尿治疗市场规模和预测(2021-2031 年)”报告对以下领域进行了详细的市场分析:
- 血尿治疗市场规模及全球、区域和国家层面所有主要细分市场的预测
- 血尿治疗市场趋势以及市场动态,如驱动因素、限制因素和关键机会
- 详细的 PEST/波特五力分析和 SWOT 分析
- 血尿治疗市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
- 行业格局和竞争分析,包括市场集中度、热点图分析、知名参与者以及血尿治疗市场的最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Compounding Pharmacies Market
- Truck Refrigeration Market
- Drain Cleaning Equipment Market
- Battery Testing Equipment Market
- Electronic Signature Software Market
- Intradermal Injection Market
- Dealer Management System Market
- UV Curing System Market
- Redistribution Layer Material Market
- Batter and Breader Premixes Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the hematuria treatment market in 2023
The key factors that are driving the growth of the market are the high prevalence of hematuria-associated indications, increasing awareness about treatment options, and improving healthcare expenditure are factors propelling the hematuria treatment market.
A rise in Preference for Advanced Therapies will likely remain a key trend in the market.
AstraZeneca, Merck & Co., Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Novartis AG, Pfizer Inc., Boehringer Ingelheim International GmbH.
The market is expected to register a CAGR of 2.5% during 2023–2031.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.